MCID: TST023
MIFTS: 29

Testotoxicosis malady

Categories: Genetic diseases, Rare diseases

Aliases & Classifications for Testotoxicosis

About this section

Aliases & Descriptions for Testotoxicosis:

Name: Testotoxicosis 47 67
Sexual Precocity, Familial, Gonadotropin-Independent 47 26
Familial Testotoxicosis 47 67
Precocious Puberty, Male Limited 47
 
Male-Limited Precocious Puberty 24
Precocious Puberty 67
Pubertas Praecox 47

Classifications:



Summaries for Testotoxicosis

About this section
Wikipedia:70 Familial male-limited precocious puberty, often abbreviated as FMPP, also known as familial sexual... more...

MalaCards based summary: Testotoxicosis, also known as sexual precocity, familial, gonadotropin-independent, is related to precocious puberty, male and familial male-limited precocious puberty, and has symptoms including decreased libido, increased libido and pain in testicle. An important gene associated with Testotoxicosis is LHCGR (Luteinizing Hormone/Choriogonadotropin Receptor), and among its related pathways are Ovarian steroidogenesis and Ovarian Infertility Genes. The drugs gonadorelin acetate and gonadorelin have been mentioned in the context of this disorder. Affiliated tissues include pituitary, and related mouse phenotype adipose tissue.

Related Diseases for Testotoxicosis

About this section

Graphical network of diseases related to Testotoxicosis:



Diseases related to testotoxicosis

Symptoms for Testotoxicosis

About this section

UMLS symptoms related to Testotoxicosis:


decreased libido, increased libido, pain in testicle, epididymal tenderness, spermatic cord pain

Drugs & Therapeutics for Testotoxicosis

About this section

Drugs for Testotoxicosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Anastrozoleapproved, investigationalPhase 2272120511-73-12187
Synonyms:
.alpha.,alpha.,.alpha.',.alpha.'-tetramethyl-5(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
1,3-benzenediacetonitrile, a, a, a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)
120511-73-1
2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)
2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)
2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)
2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile
AC-4234
AC1L1D49
Anastrazole
Anastrole
Anastrozol
Anastrozole (JAN/USAN/INN)
Anastrozole [USAN:INN:BAN]
Arimidex
Arimidex (TN)
Arimidex (Zeneca)
Arimidex, Anastrozole
Asiolex
Astra brand of anastrozole
AstraZeneca brand of anastrozole
C08159
C090450
C17H19N5
CHEBI:2704
CHEMBL1399
CID2187
CPD000466301
 
D00960
DB01217
HMS2052M11
HMS2089N10
HSDB 7462
I06-0021
ICI D1033
ICI-D 1033
ICI-D1033
LS-29563
MLS000759396
MLS001424217
MolPort-005-933-078
NCGC00164619-01
NSC719344
S1188_Selleck
SAM001246525
SBB066057
SMR000466301
UNII-2Z07MYW1AZ
ZD 1033
ZD-1033
ZD1033
ZINC00000941
Zeneca ZD 1033
Zeneca brand of anastrozole
alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
anastrazole
anastrozole
2
BicalutamideapprovedPhase 217090357-06-556069, 2375
Synonyms:
(+-)-4'-Cyano-alpha,alpha,alpha-trifluoro-3-((p-fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide
4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide
90357-06-5
AC-4232
AC1L1DJE
Astra brand of bicalutamide
AstraZeneca brand of bicalutamide
BRN 5364666
Bicalutamide (JAN/USP/INN)
Bicalutamide [USAN:INN:BAN]
C053541
C08160
C18H14F4N2O4S
CHEMBL409
CID2375
CPD000466329
Casodex
Casodex (TN)
Casodex, Cosudex, Calutide, Kalumid, Bicalutamide
Cosudex
D00961
DB01128
FT-0080576
 
HMS2051B13
HMS2089N12
I06-0475
I06-0480
ICI 176334
ICI-176334
KS-1161
LS-119125
MLS000759437
MLS001424047
MolPort-003-845-034
MolPort-006-808-679
N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide
NCGC00167977-01
NCGC00167977-02
NSC722665
Propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-,
Raffolutil
S1190_Selleck
SAM001246612
SMR000466329
TL8005814
Zeneca brand of bicalutamide
bicalutamide
propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-,(+-)
3Hormone AntagonistsPhase 212778
4HormonesPhase 213979
5Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 212767
6Steroid Synthesis InhibitorsPhase 21718
7EstrogensPhase 22470
8Estrogen AntagonistsPhase 21315
9Antineoplastic Agents, HormonalPhase 25407
10Aromatase InhibitorsPhase 2807
11Androgen AntagonistsPhase 2308
12AndrogensPhase 21275

Interventional clinical trials:

idNameStatusNCT IDPhase
1Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]Active, not recruitingNCT00094328Phase 2

Search NIH Clinical Center for Testotoxicosis

Inferred drug relations via UMLS67/NDF-RT45:

Genetic Tests for Testotoxicosis

About this section

Genetic tests related to Testotoxicosis:

id Genetic test Affiliating Genes
1 Gonadotropin-Independent Familial Sexual Precocity26

Anatomical Context for Testotoxicosis

About this section

MalaCards organs/tissues related to Testotoxicosis:

35
Pituitary

Animal Models for Testotoxicosis or affiliated genes

About this section

MGI Mouse Phenotypes related to Testotoxicosis:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053759.1CYP19A1, LHCGR

Publications for Testotoxicosis

About this section

Articles related to Testotoxicosis:

(show all 28)
idTitleAuthorsYear
1
Reply; Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene. (26757946)
2016
2
Cosegregation of a novel mutation in the sixth transmembrane segment of the luteinizing/choriogonadotropin hormone receptor with two Brazilian siblings with severe testotoxicosis. (27532428)
2016
3
Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists. (27601019)
2016
4
Letter to the Editor regarding "Testotoxicosis: Report of Two Cases, One with a Novel Mutation in Luteinizing Hormone/Choriogonadotropin Receptor Gene". (26777051)
2015
5
Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene. (26831561)
2015
6
Third-generation Aromatase Inhibitor Improved Adult Height in a Japanese Boy with Testotoxicosis. (24790387)
2014
7
Mixed germ cell tumour after testotoxicosis. (24467671)
2014
8
Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT). (21158211)
2010
9
Bicalutamide and third-generation aromatase inhibitors in testotoxicosis. (20713483)
2010
10
Mother-to-son transmission of a luteinizing hormone receptor activating mutation in a prepubertal child with testotoxicosis. (19492585)
2009
11
Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor. (20333877)
2009
12
Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. (18088394)
2008
13
An update on the treatment of precocious puberty in McCune-Albright syndrome and testotoxicosis. (17663289)
2007
14
Variable presentation of precocious puberty associated with the D564G mutation of the LHCGR gene in children with testotoxicosis. (16887451)
2006
15
Preclinical diagnosis of testotoxicosis in a boy with an activating mutation of the luteinizing hormone receptor. (16759041)
2006
16
Testotoxicosis: current viewpoint. (16361981)
2005
17
Severe testotoxicosis phenotype associated with Asp578-->Tyr mutation of the lutrophin/choriogonadotrophin receptor gene. (9598734)
1998
18
Testotoxicosis proved by immunohistochemical analysis and successfully treated with cyproterone acetate. (8912454)
1996
19
Concurrent hormone resistance (pseudohypoparathyroidism type Ia) and hormone independence (testotoxicosis) caused by a unique mutation in the G alpha s gene. (8809352)
1996
20
Identification of constitutively activating mutation of the luteinising hormone receptor in a family with male limited gonadotrophin independent precocious puberty (testotoxicosis). (7562970)
1995
21
Testotoxicosis. An unusual presentation and novel gene mutation. (7628171)
1995
22
Hazards of ketoconazole therapy in testotoxicosis. (7819701)
1994
23
Familial testotoxicosis. (7875868)
1994
24
Familial testotoxicosis in a Chinese family. (8194554)
1994
25
Testotoxicosis: gonadotrophin-independent male sexual precocity. (1589386)
1992
26
Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis. (3917500)
1985
27
Testicular changes in gonadotropin-independent familial male sexual precocity. Familial testotoxicosis. (3901957)
1985
28
Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. (6223935)
1983

Variations for Testotoxicosis

About this section

Clinvar genetic disease variations for Testotoxicosis:

5 (show all 11)
id Gene Variation Type Significance SNP ID Assembly Location
1LHCGRNM_000233.3(LHCGR): c.1733A> G (p.Asp578Gly)SNVPathogenicrs121912518GRCh37Chr 2, 48915203: 48915203
2LHCGRNM_000233.3(LHCGR): c.1713G> A (p.Met571Ile)SNVPathogenicrs121912519GRCh37Chr 2, 48915223: 48915223
3LHCGRNM_000233.3(LHCGR): c.1730C> T (p.Thr577Ile)SNVPathogenicrs121912521GRCh37Chr 2, 48915206: 48915206
4LHCGRNM_000233.3(LHCGR): c.1715C> T (p.Ala572Val)SNVPathogenicrs121912522GRCh37Chr 2, 48915221: 48915221
5LHCGRNM_000233.3(LHCGR): c.1193T> C (p.Met398Thr)SNVPathogenicrs121912526GRCh37Chr 2, 48915743: 48915743
6LHCGRNM_000233.3(LHCGR): c.1118C> T (p.Ala373Val)SNVPathogenicrs121912528GRCh37Chr 2, 48915818: 48915818
7LHCGRNM_000233.3(LHCGR): c.1624A> C (p.Ile542Leu)SNVPathogenicrs121912531GRCh37Chr 2, 48915312: 48915312
8LHCGRNM_000233.3(LHCGR): c.1103T> C (p.Leu368Pro)SNVPathogenicrs121912533GRCh37Chr 2, 48915833: 48915833
9LHCGRNM_000233.3(LHCGR): c.1703C> T (p.Ala568Val)SNVPathogenicrs121912534GRCh37Chr 2, 48915233: 48915233
10LHCGRNM_000233.3(LHCGR): c.1370T> G (p.Leu457Arg)SNVPathogenicrs121912535GRCh37Chr 2, 48915566: 48915566
11LHCGRNM_000233.3(LHCGR): c.1691A> G (p.Asp564Gly)SNVPathogenicrs121912540GRCh37Chr 2, 48915245: 48915245

Expression for genes affiliated with Testotoxicosis

About this section
Search GEO for disease gene expression data for Testotoxicosis.

Pathways for genes affiliated with Testotoxicosis

About this section

Pathways related to Testotoxicosis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.1CYP19A1, LHCGR
29.1CYP19A1, LHCGR

GO Terms for genes affiliated with Testotoxicosis

About this section

Sources for Testotoxicosis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet